ALXN

Alexion Pharmaceuticals, Inc. News Headlines

$183.24
*  
4.81
2.56%
Get ALXN Alerts
*Delayed - data as of Jan. 30, 2015  -  Find a broker to begin trading ALXN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
If Achillion's Hep C Nucleotide Isn't Best In Class, The Stock Is Worth Low Single Digits
9/16/2014 8:00:00 AM - Seeking Alpha


Is Intercept Pharmaceuticals Building The Next Great Specialty Franchise?
9/15/2014 2:30:00 PM - Seeking Alpha


Alexion's Asfotase Alfa Gets Japanese Orphan Drug Status - Analyst Blog
9/9/2014 4:30:00 PM - Zacks.com


Alexion Pharmaceuticals' Soliris Wins NICE Backing for aHUS - Analyst Blog
9/4/2014 4:00:00 PM - Zacks.com


IBB, CELG, BIIB, ALXN: ETF Outflow Alert
9/2/2014 10:18:23 AM - BNK Invest


Pfizer's C. Difficile Vaccine Gets Fast Track Status - Analyst Blog
8/29/2014 5:10:00 PM - Zacks.com


Isis Pharmaceuticals Starts Phase III Study on ISIS-APOCIIIRx - Analyst Blog
8/29/2014 3:55:00 PM - Zacks.com


Repros Reports Encouraging Late-Stage Data on Androxal - Analyst Blog
8/28/2014 3:30:00 PM - Zacks.com


Biotech Stock Roundup: Biotechs Surge on InterMune Acquisition Deal, Focus on More M&As - Analyst Blog
8/27/2014 9:32:00 AM - Zacks.com


Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q2 2014 Update
8/23/2014 10:34:00 AM - Seeking Alpha


Cramer's Mad Money - 12 Stocks That Have Performed Better Than Google (8/21/14)
8/22/2014 6:22:00 AM - Seeking Alpha


Biotech Stock Roundup: Achillion Scores in Mid-Stage Study, Gilead's Sovaldi Remains in Focus - Analyst Blog
8/20/2014 10:08:00 AM - Zacks.com


Amgen (AMGN) Reports Encouraging Top-Line Data on AMG 416 - Analyst Blog
8/19/2014 4:25:00 PM - Zacks.com


12 Top Consensus Stock Holdings From Best 3 Health Care Active Mutual Funds
8/10/2014 10:54:00 AM - Seeking Alpha


Alnylam Pharmaceuticals Has Plenty On Its Plate
8/9/2014 10:36:00 AM - Seeking Alpha


VIVUS Reports Narrower-than-Expected Loss on Qsymia Sales - Analyst Blog
8/8/2014 10:00:00 AM - Zacks.com


Orexigen Therapeutics Reports Wider Q2 Loss as Costs Mount - Analyst Blog
8/8/2014 8:20:00 AM - Zacks.com


NPS Pharma Reports Earnings in Q2 on Strong Gattex Sales - Analyst Blog
8/7/2014 11:40:00 AM - Zacks.com


Vertex's Price And Prospects Compared To Alexion
8/7/2014 10:50:00 AM - Seeking Alpha


Noteworthy ETF Inflows: TQQQ, ATVI, AKAM, ALXN
8/6/2014 9:49:53 AM - BNK Invest


Actavis Beats on Q2 Earnings & Revs, Provides 2015 Outlook - Analyst Blog
8/5/2014 1:00:00 PM - Zacks.com


Alkermes Reports Loss in Q2 on Higher Costs, Revenues Up - Analyst Blog
8/4/2014 2:40:00 PM - Zacks.com


Arena Pharmaceuticals Falls on Wider-than-Expected Q2 Loss - Analyst Blog
8/4/2014 10:10:00 AM - Zacks.com


Dr. Reddy's (RDY) Q1 Earnings and Revenues Rise Y/Y - Analyst Blog
8/1/2014 2:20:00 PM - Zacks.com


Aegerion Q2 Loss Narrower than Expected, 2014 View Retained - Analyst Blog
7/30/2014 2:15:00 PM - Zacks.com